Mexican Academic Consortium for Clinical Data Acquisition SC, Sinaloa 80230, Mexico.
Dobney Hypertension Centre, Medical School, University of Western Australia, Perth 6000, Australia.
Medicina (Kaunas). 2024 Aug 15;60(8):1323. doi: 10.3390/medicina60081323.
The development of percutaneous coronary intervention (PCI) has been one of the greatest advances in cardiology and has changed clinical practice for patients with coronary artery disease (CAD). Despite continuous improvements in operators' experience, techniques, and the development of new-generation devices, significant challenges remain in improving the efficacy of PCI, including calcification, bifurcation, multivascular disease, stent restenosis, and stent thrombosis, among others. The present review aims to provide an overview of the current status of knowledge of endovascular revascularization in CAD, including relevant trials, therapeutic strategies, and new technologies addressing particular scenarios that can impact the prognosis of this vulnerable population.
经皮冠状动脉介入治疗（PCI）的发展是心脏病学领域的重大进展之一，改变了冠心病患者的临床实践。尽管术者经验、技术和新一代器械不断改进，但在提高 PCI 的疗效方面仍存在重大挑战，包括钙化、分叉病变、多血管病变、支架再狭窄和支架内血栓形成等。本综述旨在概述 CAD 血管内血运重建的现状，包括相关试验、治疗策略和新技术，以解决可能影响这一脆弱人群预后的特定情况。
